Mirati Therapeutics (MRTX) PT Lowered to $42 at JPMorgan
Tweet
Share
E-mailGet Alerts MRTX Hot Sheet
Price: $58.70 --0%
Rating Summary:
8 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
8 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
JPMorgan analyst Eric Joseph lowered the price target on Mirati Therapeutics (NASDAQ: MRTX) to $42.00 (from $53.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Globe Telecom (GLO:PM) (GTMEY) PT Lowered to PHP1,930 at Macquarie
- SECOM Co Ltd. (9735:JP) PT Raised to JPY6,900 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
